Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Actinium Pharmaceuticals Inc. (ATNM)

0.24   0.008 (3.45%) 07-15 16:00
Open: 0.24 Pre. Close: 0.232
High: 0.24 Low: 0.23
Volume: 460,526 Market Cap: 39M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.24 - 0.242 0.242 - 0.243
Low: 0.227 - 0.228 0.228 - 0.23
Close: 0.227 - 0.23 0.23 - 0.232

Technical analysis

as of: 2019-07-15 4:40:22 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.30     One year: 0.33
Support: Support1: 0.23    Support2: 0.19
Resistance: Resistance1: 0.26    Resistance2: 0.28
Pivot: 0.24
Moving Average: MA(5): 0.24     MA(20): 0.25
MA(100): 0.39     MA(250): 0.51
MACD: MACD(12,26): -0.01     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 8.52     %D(3): 15.43
RSI: RSI(14): 34.99
52-week: High: 0.87  Low: 0.23  Change(%): -70.6
Average Vol(K): 3-Month: 161979  10-Days: 52404

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ATNM has closed above bottom band by 10.9%. Bollinger Bands are 78.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ATNM's normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 18 Apr 2019 20:22:39 Z
Mid-Afternoon Market Update: Pier 1 Imports Falls On Downbeat Q4 Results; Mustang Bio Shares Climb

Thu, 18 Apr 2019 18:27:35 Z
Mid-Day Market Update: Dow Up Over 100 Points; Actinium Pharmaceuticals Shares Plunge

Thu, 04 Apr 2019 16:09:14 Z
The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy

Wed, 03 Apr 2019 15:05:41 Z
Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy

Mon, 01 Apr 2019 15:35:23 Z
What Makes Actinium (ATNM) a New Buy Stock

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 162.03
Shares Float (M) 147.46
% Held by Insiders 1.30
% Held by Institutions 12.47
Shares Short (K) 2460
Shares Short P. Month (K)

Stock Financials

EPS -0.203
EPS Est. Current Year -0.400
EPS Est. Next Year -0.250
EPS Est. Next Quarter -0.080
Forward EPS -0.090
Book Value (p.s.) 0.050
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -71.7
Return on Equity (ttm) -169.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.142
Qtrly Earnings Growth
Operating Cash Flow (M) -20.60
Levered Free Cash Flow (M) -13.44

Stock Valuations

P/E -1.15
P/E Growth Ratio
P/BV 4.65
P/CF -1.83

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.